Atossa Therapeutics
ATOS
#9938
Rank
HK$0.38 B
Marketcap
HK$45.18
Share price
-6.48%
Change (1 day)
809.98%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -HK$1.95

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$1.96. In 2024 the company made an earnings per share (EPS) of -HK$1.57 an increase over its 2023 EPS that were of -HK$1.88.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$1.9524.49%
2024-HK$1.57-16.67%
2023-HK$1.8814.29%
2022-HK$1.6416.67%
2021-HK$1.41-90.86%
2020-HK$15.43-2.96%
2019-HK$15.90-63.09%
2018-HK$43.07-49.63%
2017-HK$85.51-57.87%
2016-HK$202.98-74.01%
2015-HK$780.89-9.18%
2014-HK$859.82-12.86%
2013-HK$986.6870.73%
2012-HK$577.9134.08%
2011-HK$431.03263.47%
2010-HK$118.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.22-4,555.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$69.46-3,648.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$82.46-4,312.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-HK$6.89 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-HK$1.64-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA